Blog

Home  /  EUnetHTA Joint Action 3 (2016-2021)   /  PTJA11 – Cefiderocol for the treatment of infections due to aerobic Gram-negative bacteria in adult patients with limited treatment options – project plan now available

PTJA11 – Cefiderocol for the treatment of infections due to aerobic Gram-negative bacteria in adult patients with limited treatment options – project plan now available

The final project plan of the relative effectiveness assessment of ‘cefiderocol for the treatment of infections due to aerobic Gram-negative bacteria in adult patients with limited treatment options’ is now available for access. The final assessment report will be published on May 28th, 2020.

Below is the documentation provided by the Joint Assessment Authoring Team:

PTJA11 – Final Project Plan